二价呼吸道合胞病毒mRNA疫苗(深信生物)(IN-006) - 在研适应症：呼吸道合胞体病毒感染_专利_临床

概要

基本信息

药物类型

预防性疫苗、mRNA疫苗

别名

二价RSV mRNA疫苗、呼吸道合胞病毒IN006二价mRNA疫苗、IN006

靶点-

作用方式

刺激剂

作用机制

免疫刺激剂

治疗领域

感染

在研适应症

呼吸道合胞体病毒感染

非在研适应症-

原研机构

深圳深信生物科技有限公司

在研机构

深圳深信生物科技有限公司

非在研机构-

权益机构-

最高研发阶段临床2期

首次获批日期-

最高研发阶段(中国)临床2期

特殊审评-

登录后查看时间轴

关联

3

项与二价呼吸道合胞病毒mRNA疫苗(深信生物) 相关的临床试验

NCT07128121

/ Recruiting临床2期

A Phase 2, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Immunogenicity of the Respiratory Syncytial Virus IN006 Bivalent mRNA Vaccine (IN006) in Healthy Participants Aged 60 Years and Older

The study will evaluate the safety, tolerability, and immunogenicity of 2 dose levels of IN006 in healthy participants who aged at 60 years or older; of a revaccination of IN006 given 12 months or 24 months after the initial vaccination.

开始日期2025-08-13

申办/合作机构

深圳深信生物科技有限公司

NCT06287450

/ Not yet recruiting临床1期

A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Respiratory Syncytial Virus IN006 Bivalent mRNA Vaccine (IN006) in Healthy Adult Participants

The study will evaluate the safety, tolerability, and immunogenicity of a single injection of up to 4 dose levels of IN006 in younger adults and 3 dose levels of IN006 in older adults; of a revaccination of IN006 given approximately 12 months after the initial vaccination in older adults.

开始日期2025-08-01

申办/合作机构

深圳深信生物科技有限公司

NCT06645665

/ Recruiting临床1期

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of Respiratory Syncytial Virus IN006 Bivalent mRNA Vaccine (IN006) in Healthy Adult Aged 18 Years and Above

The study will evaluate the safety, tolerability, and immunogenicity of 3 dose levels of IN006 in healthy adults aged 18 Years and Above; of a revaccination of IN006 given approximately 12 months after the initial vaccination in older adults (aged ≥60 years).

开始日期2024-11-11

申办/合作机构

深圳深信生物科技有限公司

100 项与二价呼吸道合胞病毒mRNA疫苗(深信生物) 相关的临床结果

登录后查看更多信息

100 项与二价呼吸道合胞病毒mRNA疫苗(深信生物) 相关的转化医学

登录后查看更多信息

100 项与二价呼吸道合胞病毒mRNA疫苗(深信生物) 相关的专利（医药）

登录后查看更多信息

100 项与二价呼吸道合胞病毒mRNA疫苗(深信生物) 相关的药物交易

登录后查看更多信息